Low-dose lithium adjunct to antipsychotic agent use had a nearly significant effect on the reduction of cognitive impairment relative to placebo.
← all excerpts
Low-dose lithium adjunct to atypical antipsychotic treatment nearly improved cognitive impairment, deteriorated the gray-matter volume, and decreased the interleukin-6 level in drug-naive patients with first schizophrenia symptoms: a follow-up pilot study.
1
—
—